| Application no. and date | 12798470.6 (espacenet) (Federated) (European Patent Register), 20121031 | | Patent/reg. no. and date | DK/EP 2773331, 20160210 | | Publication date | 20140910 | | Priority no. and date | US 201161553388 P, 20111031, US 201261609123 P, 20120309 | | EP pub. no. and date |
EP 2773331 20140910 | | Effective date | | | Applicant/owner | Xeris Pharmaceuticals, Inc., 3208 Red River, Suite 300
Austin TX 78705, US | | Applicant ref. no. | 159287 | | Inventor | PRESTRELSKI, Steven, c/o Xeris Pharmaceuticals Inc.
3208 Red River, Suite 300
Austin, TX 78705, US,
SCOTT, Nancy, c/o Xeris Pharmaceuticals Inc.
3208 Red River,
Suite 300
Austin, TX 78705, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/22 (2006.01) , A61K 38/28 (2006.01) , A61K 47/20 (2006.01) , A61K 9/00 (2006.01) , A61K 9/14 (2006.01) , A61K 9/19 (2006.01) | | Title | Formuleringer til behandling af diabetes | | Int. application no. | US2012062816 | | Int. publication no. | WO2013067022 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
